Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.44 USD | +1.74% | -1.38% | +41.54% |
03-19 | North American Morning Briefing : Stock Futures -2- | DJ |
03-14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 411M 32.89B |
---|---|---|---|---|---|
Net income 2024 * | -79M -6.32B | Net income 2025 * | -144M -11.53B | EV / Sales 2024 * | - |
Net cash position 2024 * | 182M 14.59B | Net cash position 2025 * | 57.6M 4.61B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.23
x | P/E ratio 2025 * |
-3.07
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.66% |
Latest transcript on Larimar Therapeutics, Inc.
1 day | +1.74% | ||
1 week | -1.38% | ||
Current month | -15.15% | ||
1 month | -11.36% | ||
3 months | +31.70% | ||
6 months | +142.11% | ||
Current year | +41.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 27/05/20 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 27/05/20 |
Frank Thomas
BRD | Director/Board Member | 54 | 27/05/20 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 02/10/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.44 | +1.74% | 144,231 |
25/04/24 | 6.33 | -2.01% | 302,131 |
24/04/24 | 6.46 | 0.00% | 222,439 |
23/04/24 | 6.46 | +0.94% | 243,953 |
22/04/24 | 6.4 | -1.99% | 238,190 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.54% | 411M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LRMR Stock